Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu)

A. A. Geldof, B. R. Rao

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Doxorubicin (Dx) effects on metastatic spreading of prostate cancer were investigated using a rat metastatic tumor (R3327-MatLyLu). Intravenous injection of monodispersed tumor cells resulted in tumor nodule formation in the lungs. A simultaneous bolus injection of Dx (3.2 mg/Kg) caused a significant decrease in lung colony formation and growth. However, Dx administered during the course of spontaneous metastasis, or as adjuvant chemotherapy 24 hours before surgical removal of primary tumor, caused a significant increase in metastasis to the lungs. It is concluded that an intravenous doxorubicin bolus injection does not provide an antimetastatic effect, but increases metastastic spreading of prostate tumor.

Original languageEnglish
Pages (from-to)1335-1339
Number of pages5
JournalAnticancer Research
Volume8
Issue number6
Publication statusPublished - 1 Dec 1988

Cite this